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Edited by Julian SchroederAbstract RNA interference (RNAi) can be used to study gene
function by eﬀecting degradation of the targeted transcript.
However, the eﬀectiveness of transgene-induced RNAi among
multiple target genes has not been compared systematically. To
this end, we developed a relative quantitative RT-PCR protocol
that allows use of a single internal standard over a wide range of
target gene expression levels. Using this method in an analysis of
transgenic Arabidopsis thaliana RNAi lines targeting 25 diﬀer-
ent endogenes revealed that independent, homozygous, single-
copy (sc) T4 lines targeting the same gene generally reduce
transcript levels to the same extent, whereas multi-copy RNAi
lines diﬀered in the degree of target reduction and never exceeded
the eﬀect of sc transgenes. The maximal reduction of target
transcript levels varied among targets. These observations
suggest that each target sequence possesses an inherent degree
of susceptibility to dsRNA-mediated degradation.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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A preferred method for delivering dsRNA to plants for in-
ducing RNA interference (RNAi) is to introduce transgenes
engineered to express self-complementary transcripts that can
‘fold back’ to form dsRNA molecules [1]. The principal ad-
vantage of integrated transgenes over transiently introduced
dsRNA is that the silencing phenotype is sexually transmissi-
ble, and so permanent collections of stable RNAi lines can be
produced and archived in public repositories.
RNAi induced by dsRNA-producing transgenes targeting a
variety of endogenous genes in plants has been shown to result
in a high frequency of mutant phenotypes among independent
transformants [2–5]. The eﬀectiveness of RNAi was catego-
rized primarily on the basis of the phenotypic eﬀects observed
for a given target gene, and the plants analyzed were mostly
mixed populations of transformants carrying single or multiple
inserts of the dsRNA producing transgene in either hemi- or
homozygous condition.* Corresponding author. Fax: +1-520-621-7186.
E-mail address: amuller@ag.arizona.edu (A.E. Mu¨ller).
Abbreviations: RNAi, RNA interference; GAPC, glyceraldehyde-3-
phosphate dehydrogenase C subunit gene
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doi:10.1016/j.febslet.2004.04.043Here, we analyzed the eﬀectiveness of RNAi among multiple
target genes in Arabidopsis thaliana systematically by identi-
fying RNAi lines that each carry only a single-copy (sc) of the
transgene, in the homozygous condition, and by using a single
internal control for relative quantitative RT-PCR analysis of
target transcript concentration. We found that independent, sc
RNAi lines targeting the same gene generally reduced target
transcript levels to a similar extent, and the maximal degree of
reduction of target transcripts appears to be target-speciﬁc. By
contrast, multi-copy (mc) RNAi lines analyzed side-by-side
with sc lines frequently reduced target RNA levels to a lesser
extent and with more variability between lines than did sc lines.2. Materials and methods
2.1. Generation of RNAi lines
RNAi vectors pFGC1008 and pFGC5941 (GenBank Accession Nos.
AY310333 and AY310901, respectively; Arabidopsis Biological Re-
source Center (ABRC) stock numbers CD3-446 and CD3-447, re-
spectively) were derived from pCAMBIA1200 and pCAMBIA1300,
respectively, and used to produce dsRNA-producing transgenes. The
constructs are available from the ABRC and maps are displayed at
www.chromdb.org. Each RNAi construct contained a cDNA fragment
(0.4–0.8 kb) derived from the respective target gene and oriented as an
inverted repeat with each repeat separated by either a fragment from
the b-glucuronidase gene (pFGC1008) or an intron from the Petunia
hybrida Chalcone synthase A gene (pFGC5941).
RNAi lines were produced using Agrobacterium tumefaciens
LBA4404-mediated germ-line transformation of A. thaliana accession
Wassilewskija (Ws) essentially as described by Clough and Bent [6]. sc
transformants were identiﬁed by DNA gel blot hybridization using
plant genomic DNA digested with NcoI (pFGC1008-derived con-
structs) or EcoRI (pFGC5941-derived constructs) and random-primed
probes speciﬁc for regions adjoining the left and right T-DNA borders
to discriminate mc insertions from sc insertions. sc transformants were
allowed to self-pollinate and homozygous lines were identiﬁed by
segregation analysis. A list of all available RNAi lines, including
ABRC stock numbers, is available upon request or can be viewed at
www.chromdb.org.
2.2. Total RNA extraction
Total RNA was extracted from 10-day-old seedlings grown on MS
medium supplemented with 3% sucrose under standard growth con-
ditions (24 C, 16 h light). Approximately 150 mg of seedlings was
transferred to 1.5-ml microfuge tubes and subsequently frozen in liquid
nitrogen. The frozen tissue was ground using a disposable small plastic
pestle. 0.5 ml of NTES buﬀer (100 mM NaCl, 10 mM Tris, pH 7.5, 1
mM EDTA, and 1% SDS) was added to each tube, the tissue vortexed,
and the contents of the tubes extracted with phenol:chloroform:iso-
amyl alcohol (25:24:1) and chloroform:iso-amyl alcohol (24:1). The
RNA was precipitated in the presence of 2 M lithium acetate for a
minimum time of 3 h on ice to a maximum time of overnight at 4 C.
The RNA was pelleted by centrifugation for 15 min at 4 C, the su-
pernatant removed, and the pellet resuspended in water. Finally, the
RNA was precipated in the presence of 0.3 M sodium acetate and 2.5blished by Elsevier B.V. All rights reserved.
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pended in 50 ll of water.
2.3. Reverse transcription
5 lg of total RNAwas denatured at 70 C for 10min in the presence of
3.33 lMoligo(dT)12–18 primers. The tube was immediately chilled on ice
and reverse-transcribed with 5 U MMLV reverse transcriptase (Pro-
mega Co., Madison, WI), 0.5 mM of each dNTP, and 20 U RNasin
(Promega,Madison, WI) in a total reaction volume of 30 ll at 42 C for
50 min. The reaction was heat-inactivated at 70 C for 15 min. The
resultant ﬁrst-strand cDNAwas puriﬁed by subsequent extractions with
phenol:chloroform:isoamyl alcohol (25:24:1) and chloroform:isoamyl
alcohol (24:1), precipitated in the presence of 0.3 M sodium acetate and
2.5 volumes of 95% ethanol, and resuspended in 25 ll of water.
2.4. Polymerase chain reaction
Polymerase chain reaction (PCR) was performed using 0.5 ll of un-
diluted or diluted cDNA template, 0.5 U Taq polymerase (Sigma–Al-
drich Co., USA), 1 Taq polymerase reaction buﬀer (Sigma–Aldrich,
USA), 2 mMMgCl2, 100 lMof each dNTP, and 500 nM target-speciﬁc
primers (MWG Biotech AG, Ebersberg, Germany). Thermocycler
conditions included an initial denaturation at 94 C for 2 min, followed
by 32 cycles consisting of 94 C for 30 s, 60 C for 30 s, and 72 C for 30 s,
and a ﬁnal synthesis step at 72 C for 7 min. PCR products were run in
1.2% agarose gels using 0:5 TBE and stained with ethidium bromide.Fig. 1. RT-PCR ampliﬁcation of HDA5 and control transcripts using ampliﬁ
gene were co-ampliﬁed with GAPC as an endogenous control transcript u
thaliana wild-type ﬁrst-strand cDNA diluted 1/25 was used as template for 32
by gel electrophoresis. Comparable amounts of the GAPC and HDA5 ampli
included in the reaction. Lanes 2–11, PCR products resulting from ampliﬁ
primers and GAPC primers F1 and R using 0% (3), 15% (4), 20% (5), 25% (6
F10 and R0. (B) GAPC andHDA5 were co-ampliﬁed in the presence of 32% GA
ﬁrst-strand cDNA template. The ampliﬁcation product ratio of the two transc
(C) GAPC ampliﬁcation kinetics. GAPC was ampliﬁed without (top) and wi
numbers (18–38). Signal intensities of the ethidium bromide-stained ampliﬁc
analysis software and plotted against cycle numbers (y-axis¼background-cor
of PCR cycles within the exponential phase of ampliﬁcation were calculated
kinetics of GAPC and HDA5. GAPC and HDA5 were co-ampliﬁed using 32%
(28–36), and signal intensities were quantiﬁed and plotted against cycle num
Beverly, MA); M2, 100-bp ladder (Invitrogen Co., Carlsbad, CA); inh., GAPCR product amounts were estimated visually by comparison with
DNA standards or quantiﬁed using the UVP LabWorksTM 3.0 image
analysis software (UVP Inc., Upland, CA). The eﬃciency of ampliﬁ-
cation for a range of PCR cycles within the exponential phase of
ampliﬁcation was calculated according to the formula En1n2 ¼
ðAn2=An1Þ1=ðn2n1Þ 1, where n1 and n2 are the ﬁrst and last cycle number
of a given range, An1 and An2 are the amounts of amplicons produced
after n1 or n2 cycles and E is the eﬃciency of ampliﬁcation (a value of 1
would indicate 100% eﬃciency).
2.5. Relative quantitative RT-PCR
During the exponential phase of PCR-ampliﬁcation, a target tem-
plate is expected to amplify according to the equation:
An ¼ A0ð1þ EÞn ð1Þ
where A0 is the amount of initial template DNA, n is the number of
cycles of ampliﬁcation, An is the amount of speciﬁc product after n
cycles, and E is the eﬃciency of each cycle of ampliﬁcation [7]. When
co-ampliﬁed with a biologically invariant reference transcript B, the
ratio of amplicons produced from A and B can be expressed as:
An=Bn ¼ A0ð1þ EAÞn=B0ð1þ EBÞn ð2Þ
where EA and EB represent the speciﬁc eﬃciencies of ampliﬁcation of
transcripts A or B, respectively.
The factor X by which the initial amount of transcript diﬀers be-
tween two samples can be expressed ascation inhibitors. (A) Transcripts derived from the A. thaliana HDA5
sing increasing concentrations of GAPC ampliﬁcation inhibitors. A.
cycles of PCR ampliﬁcation, and ampliﬁcation products were separated
cons were produced when 30–35% GAPC ampliﬁcation inhibitors were
cation with HDA5 primers alone (2), or co-ampliﬁcation with HDA5
), 30% (7), 35% (8), 40% (9), 45% (10) or 50% (11) of GAPC inhibitors
PC ampliﬁcation inhibitors and using decreasing concentrations of the
ripts remained similar over the range of template concentrations tested.
th 32% of ampliﬁcation inhibitors (bottom) over a range of PCR cycle
ation products were quantiﬁed using the UVP LabWorksTM 3.0 image
rected total density values). The eﬃciencies of ampliﬁcation for a range
according to the formula given in Section 2.4. (D) Co-ampliﬁcation
of GAPC ampliﬁcation inhibitors over a range of PCR cycle numbers
bers as described in (C). M1, 1-kb ladder (New England Biolabs, Inc.,
PC ampliﬁcation inhibitors.
n n
Fig. 2. Co-ampliﬁcation of HDA5 and control cDNA using decreasing
concentrations of HDA5 cDNA. (A) HDA5 and GAPC were co-am-
pliﬁed from a mixture of puriﬁed HDA5 and GAPC cDNA fragments.
HDA5 and GAPC fragments were ampliﬁed separately from wild-type
ﬁrst-strand cDNA and gel-puriﬁed (QIAquick Gel Extraction Kit,
Qiagen, Hilden, Germany). The puriﬁed cDNA fragments were diluted
to ensure that PCR ampliﬁcation remained within the exponential
phase after 32 cycles (see Section 2.5) and then mixed at a ratio that
produced similar amounts of amplicons after 32 cycles of PCR (using a
GAPC ampliﬁcation inhibitor concentration of 32%) (lane 2). In par-
allel reactions, the concentration ofHDA5 cDNA that was added to the
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where B20=B10 represents the normalization factor that accounts for
sample to sample variability. X was determined experimentally by
quantiﬁcation of the PCR products A1n, B1n, A2n and B2n as described
in Section 2.4.
For the purpose of this study, glyceraldehyde-3-phosphate dehy-
drogenase C subunit gene (GAPC) was chosen as an internal standard
for relative quantitative RT-PCR assays. The following generalized
procedures describe the relative quantitative RT-PCR protocol used
for all RNAi lines assayed in this study.
Primer and inhibitor design. GAPC was ampliﬁed using either primer
pair F1 (50-CTGTCAACGACCCCTTCATC-30) and R (50-CCTG-
TTGTCGCCAACGAAGTC-30) or primer pair F2 (5-CACTTGA-
AGGGTGGTGCCAAG-30) and R, yielding ampliﬁcation products of
785 or 543 bp, respectively. The corresponding GAPC ampliﬁcation
inhibitors were F10 ¼ 50-GCTCGTCGCTGTCAACGACCCCTT-
CATC-dideoxyC-30, F20 ¼ 50-CTGCAGCTCACTTGAAGGGTGG-
TGCCAAG-dideoxyC-30, and R0 ¼ 50 AATGCTCGACCTGTTGTC
GCCAACGAAGTC-dideoxyC-30. HDA5 was ampliﬁed with forward
primer 50-CATAAATGTTCCATGGGATCAAG-30 and reverse pri-
mer 50-ATCAGCTCTCCAAGATGTAGATGC-30 to give a 601-bp
ampliﬁcation product. Primers speciﬁc for all endogenous transcripts
targeted by RNAi were designed to (a) amplify a fragment of the target
transcript that only partially overlaps with the fragment incorporated
into the RNAi construct, so that transgene transcripts would not be
ampliﬁed, (b) distinguish spliced transcripts from unprocessed precur-
sors or genomic DNA contamination, and (c) allow separation of the
ampliﬁcation products from the GAPC control by standard agarose gel
electrophoresis. A list of all target gene-speciﬁc primers is available
upon request.
Template dilution test. To standardize the RT-PCR assay for all
targeted transcripts, all PCRs were carried out under identical condi-
tions (see Section 2.4). Because the majority of chromatin gene tran-
scripts yielded detectable ampliﬁcation products after 32 cycles of
ampliﬁcation, this cycle number was chosen for the standardized
procedure described here. Relative quantitation of transcript levels by
RT-PCR is not accurate once the stationary phase of PCR ampliﬁ-
cation is reached [8], so the end-points of PCR ampliﬁcation being
assayed need to fall within the exponential phase of ampliﬁcation.
Since the level of expression varied widely between the chromatin genes
assayed, the template dilution required for PCR ampliﬁcation to re-
main within the exponential phase was determined for each transcript
of interest. To this end, PCRs with primers speciﬁc for individual genes
of interest were performed with template dilution series consisting of
undiluted ﬁrst-strand cDNA from wild-type A. thaliana Ws seedlings
as well as dilutions of 1/5, 1/25, and 1/125. PCR product amounts were
estimated on agarose gels by comparison with DNA standards. The
exponential phase of ampliﬁcation ends at 1012 molecules of product
under standard PCR conditions [8]. 1012 molecules of a 0.5–1.0 kb
PCR product (the size range of amplicons being tested) are 550–1100
ng. To ensure that PCR ampliﬁcation remained within the exponential
phase, a dilution was selected that would produce <100 ng of PCR
product and less PCR product than the next more concentrated tem-
plate of the dilution series.
Inhibitor concentration test. Multiplex PCRs using GAPC as the
internal control were carried out at the selected dilution and under the
same PCR conditions but with the addition of GAPC-speciﬁc primers
(500 nM each) and increasing concentrations of inhibitors (15–50% of
total GAPC-speciﬁc oligonucleotides) (MWG Biotech AG, Ebersberg,
Germany). The inhibitor concentration that produced similar amounts
of the target and the control amplicon using wild-type ﬁrst-strand
cDNA as template was selected to assay RNAi lines.GAPC cDNAwas reduced by factors of 2, 4, 8, and 16 (lanes 3–6), while
the concentration of the GAPC cDNA was kept constant. In lane 7, no
HDA5 cDNA was added. (B) The ratio of HDA5 amplicon to GAPC
amplicon signal intensities (as quantiﬁed using the UVP LabWorksTM
3.0 image analysis software and normalized against the ratio of the
HDA5 to GAPC signals in the sample with the highest (undiluted)
HDA5 concentration as template) averaged over ﬁve replicate experi-
ments was plotted against the HDA5 template concentration (solid
line). The standard deviation is indicated by error bars. The dashed line
corresponds to the diagonal that would indicate perfect linear pro-
portionality. M, Low DNA mass ladder (Invitrogen, Carlsbad, CA).3. Results and discussion
RNAi lines targeting genes predicted to encode chromatin-
associated proteins were produced by transformation of A.
thaliana with dsRNA-producing transgenes by the Plant
Chromatin Functional Genomics Consortium (www.chromdb.
org). To assess the eﬀectiveness of these transgenes systemat-ically, we identiﬁed transformants that each carry only a sc of
the transgene. These transformants were propagated by self-
fertilization, and homozygous progeny plants were assayed in
the T4 generation. Moreover, to assay the eﬀect of the trans-
gene in a standardized manner that does not rely on pheno-
typic eﬀects speciﬁc for individual target genes, we determined
to what extent the concentration of the target transcript was
aﬀected. Relative quantitative RT-PCR can be used to com-
pare target transcript levels in diﬀerent biological samples (e.g.,
wild-type vs. mutant plants) relative to another endogenous
transcript that serves as an internal standard to control for
sample-to-sample variability [8,9]. Rather than attempt to
identify and characterize many diﬀerent control transcripts to
cover the full range of target gene expression levels, we devised
a method that inhibits ampliﬁcation of a single, abundant
control transcript to whatever extent is necessary to match
its ampliﬁcation to that of any target transcript of lower
abundance.
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inhibitors of an internal control
The relative quantitative RT-PCR protocol we used
achieves inhibition of control ampliﬁcation with non-exten-
sible oligonucleotides (see Section 2.5) identical in sequence to
the control’s ampliﬁcation primers except that the non-ex-
tensible oligonucleotides terminate in a 30-dideoxynucleotide
and are extended at the 50 end in order to compete more ef-
fectively for annealing sites on the template cDNA than
would inhibitors of the same length as the primers. As control
transcript, we utilized GAPC (A. thaliana locus At3g04120),
encoding glyceraldehyde-3-phosphate dehydrogenase C sub-
unit and expressed at moderately high levels in Arabidopsis
seedlings. Fig. 1A shows the results of RT-PCR ampliﬁcation
with increasing concentrations of 30-dideoxyoligonucleotides
in the presence of primers speciﬁc for HDA5 (A. thaliana
locus #At5g61060), demonstrating that GAPC ampliﬁcation
is reduced in the presence of inhibitors (lanes 4–11). At an
inhibitor to primer molar ratio of approximately 0.5:1 (in-
hibitor concentration¼ 30–35% of total oligonucleotides), the
inhibitors were found to reduce GAPC ampliﬁcation suﬃ-
ciently to produce similar amounts of HDA5 and GAPC
products, whereas HDA5 ampliﬁcation was not reduced
(compare lanes 2 and 7–8). Under these conditions, co-am-
pliﬁcation of GAPC and HDA5 was independent of cDNA
template concentration over a 50-fold range (Fig. 1B),
showing that the method is robust against sample-to-sample
variation in cDNA quantity (as would be expected from Eq.Table 1
Target transcript accumulation in independent, homozygous sc RNAi lines




Target accumulation relative to w
<20% 20–50% >50%–
MFP1 At3g16000 6 6
HDT2 At5g22650 4 4
CHR6 At2g25170 3 3
HAG3 At5g50320 3 3
HDT4 At2g27840 3 3
NFD3 At1g20696 3 3
NFD5 At4g35570 3 3
HDA9 At3g44680 2 2
HDT1 At3g44750 2 2
SGA1 At5g38110 2 2
NFC4 At2g19520 5 4 1
HAG2 At5g56740 3 3
HAG5 At5g09740 3 2
NFA2 At2g19480 3 2
GTE1 At2g34900 4 4
HXA1 At4g16420 4 4
HDA2 At5g26040 2 2
CHE1 At3g17590 3 2 1
HXA2 At3g07740 2 1
CHR2 At2g46020 2 1





Total number of lines: 77 42 15 4
Target transcript accumulation in RNAi lines relative to wild-type Arabidopsis
position of the cDNA fragments inserted into RNAi constructs relative to th
fragment between inverted repeats are indicated (GUS, b-glucuronidase gene
aOf the two NFA2 lines with strong reduction in target RNA accumulation,
did not show any detectable reduction carries the GUS fragment as spacer.
b Partial deletion at the right border of the T-DNA insert. þIn-frame insertion(2)). The kinetics of GAPC and HDA5 ampliﬁcation in the
presence of GAPC ampliﬁcation inhibitors are shown in
Fig. 1C and D. The eﬃciency of GAPC ampliﬁcation was
reduced from 0.57 to 0.40 (Fig. 1C). HDA5 ampliﬁcation
eﬃciency was approximately twice that of the co-ampliﬁed
GAPC transcripts (Fig. 1D). (For calculation of ampliﬁcation
eﬃciencies, see Section 2.4.)
In view of the reduced concentration expected for the tar-
geted transcript in RNAi lines, we considered that due to
competition for resources during co-ampliﬁcation of target
and control molecules, target abundance might be underesti-
mated in samples in which the target transcript was much less
abundant than the control transcript. Thus, the eﬀect of dilu-
tion of the target template was investigated, keeping the con-
centration of the control template constant, as shown in Fig. 2.
The target to control product ratio was found to be directly
proportional to initial target template concentration over a
10-fold range, and so provides an accurate measure of initial
template concentration.
3.2. Eﬀectiveness of RNAi transgenes in A. thaliana
Using sc, homozygous T4 RNAi lines and relative quanti-
tative RT-PCR with a single internal control transcript as
described above, transcript accumulation was analyzed in 2–6
independent RNAi lines for each of 25 target genes (Table 1).
Representative results are shown in Fig. 3A. These results
demonstrate that the degree of reduction in transcript accu-
mulation is similar for most sc RNAi lines targeting the sameild-type IR/cds In-frame Spacer
fragment
<100% No reduction
1435–2019/2136 + CHS A
307–919/921 ) CHS A
3594–4154/4155 + CHS A
117–887/1698 ) GUS
1–603/612 + CHS A
28–423/426 + CHS A
11–375/375 ) CHS A
28–675/1257 + CHS A
1–732/738 + GUS
22–657/657 + GUS
262–975/1524 + CHS A
2–782/1405 ) CHS A
1 559–1056/1335 + CHS A
1 1–593/1140 + GUS or
CHS Aa
319–951/1161 ) CHS A
118–762/1464 + CHS A
442–1020/1023 + CHS A
1–723/723 ) GUS
1b 1–639/1647 + GUS
1 3282–3945/6582 ) GUS
2973–3804/3807 ) CHS A
4 2581–3345/5757 + CHS A
3 2764–3431/6687 ) GUS
3 58–606/1122 + CHS A
2 286–882/4406 + CHS A
16
was determined by relative quantitative RT-PCR (see Section 2.5). The
e full-length coding sequences of the genes and the origin of the spacer
fragment; CHS A, intron of the P. hybrida chalcone synthase A gene).
one carries the GUS fragment and one the CHS A intron. The line that
of the target gene cDNA fragment at the ATG of the NcoI cloning site.
A. Kerschen et al. / FEBS Letters 566 (2004) 223–228 227gene, whereas it varies dramatically among diﬀerent target
genes, with some showing little or no residual transcript RNA
(e.g., HAG3), some showing little or no reduction (e.g.,
CHR4), and others showing intermediate degrees of reduction
(e.g., HXA1 and HDA2).
The observation that target transcript reduction in RNAi
lines relative to wild-type varies among targets suggests that
each target sequence possesses an inherent degree of suscep-
tibility to RNAi. In Caenorhabditis elegans, strong RNAi ef-
fects as assessed by a phenotypic analysis were found to
correlate with high expression levels of the targeted genes [10].
RNA gel blot analysis of the genes targeted in our study
suggests that several of the genes with strongly reduced tran-
script levels in RNAi lines are expressed at moderate to high
levels in wild-type Arabidopsis seedlings (e.g., HDT1, HDT2,
and NFD3), whereas the four target genes whose transcript
levels were not detectably reduced are normally expressed at
moderately low levels (CHR4, HAF1, and NFA3) or at a level
below the detection threshold (HAC4), respectively (see
www.chromdb.org). However, we also identiﬁed genes with
low expression levels in wild-type seedlings that exhibit
strongly reduced target transcript levels in RNAi lines (e.g.,
HDA9, HDT4, and SGA1), suggesting that endogenous tran-Fig. 3. Relative quantitative RT-PCR of endogenous transcripts targeted b
mulation in wild-type (wt) A. thaliana and independent transgenic lines carryi
HDA2, and CHR4. Ampliﬁcation of GAPC as an internal standard was adju
appropriate concentrations (35–45%) of GAPC ampliﬁcation inhibitors. (B) s
lines were assayed, the mc lines showed clearly less reduction in target transcr
of the RNAi construct, the T-DNA locus number is given. For mc inserts, th
Beverly, MA), M2, 100-bp ladder (Invitrogen, Carlsbad, CA).script accumulation of the targeted gene is not the only target-
speciﬁc determinant of RNAi eﬀectiveness in Arabidopsis.
Other factors that may aﬀect RNAi eﬀectiveness in a gene-
speciﬁc manner include sequence composition, spatial and
temporal gene expression patterns, and the normal RNA
turnover rate of the targeted gene.
In addition to sc RNAi lines, we analyzed several lines
carrying multiple copies of the RNAi construct (Fig. 3B).
Although some mc lines showed reduction in transcript accu-
mulation similar to that in sc lines targeting the same tran-
script, in four out of 12 mc lines analyzed target transcript
levels were higher than in most sc lines. Also, mc transgenes
did not reduce target levels more than did sc transgenes. Pre-
vious studies demonstrated that RNAi lines targeting endog-
enous genes can produce a series of mutant phenotypes that
vary from weak phenotypes to phenotypes resembling known
null mutants of the targeted gene [2,3,5]. Our observation that
much of the variation among RNAi lines (with respect to level
of reduction of target RNA) is due to variation among mc
transformants is consistent with the likelihood that mc lines
are subject to some degree of transcriptional silencing of the
RNAi transgene, thereby reducing its eﬀectiveness. Chuang
and Meyerowitz [2] showed that RNAi constructs driven by ay RNAi. (A) sc RNAi lines. The panels show target transcript accu-
ng homozygous, sc inserts of RNAi constructs targeting HAG3, HXA1,
sted to be compatible with that of the target transcript by addition of
c and mc RNAi lines. For target genes for which both sc and mc RNAi
ipt accumulation than at least one corresponding sc line. For sc inserts
e RNAi line number is given. M1, 1-kb ladder (New England Biolabs,
228 A. Kerschen et al. / FEBS Letters 566 (2004) 223–228weaker promoter are less eﬀective than those driven by a
stronger promoter. Also, transcriptional transgene silencing
can be progressive and increase over generations and may
exhibit reversibility and somatic variability [11]. Thus,
the usefulness of mc RNAi lines may be compromised. Al-
though mc transgenes might cause greater target reduction
than sc transgenes in T1, this advantage may disappear over
generations.
Based on our ﬁndings, we recommend that functional ge-
nomics programs seeking to produce permanent collections of
RNAi lines generate sc transgenic lines in order to maximize
RNAi eﬀectiveness and stability. mc lines may be useful to
achieve intermediate eﬀects on the targeted gene, although
with the caveat that these eﬀects may be unreliable due to
progressive loss over generations, reversibility, and somatic
variability. An alternative approach to vary the degree of eﬀect
of RNAi may be to express dsRNA from transgene promoters
of diﬀerent strengths.Acknowledgements: The authors thank our colleagues in The Plant
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